Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

The review suggests that understanding and treating the psychological aspect of skin disorders is important and calls for more collaboration in this field.

Some alternative treatments for hair loss might work, but more research is needed.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Facial plastic surgery has evolved to focus on less invasive techniques and innovative technologies for cosmetic and reconstructive procedures.

Men's hair loss is caused by hormones and genes, and can be treated with medication and surgery, while graying is due to aging and has no prevention except dyeing.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Extramammary Paget disease can spread deeply into tissues, reaching up to 3.6 mm.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Using a special laser can improve how well hair loss treatments get into the skin and hair follicles.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

PRP treatment helps hair growth and density with 70.7% success, but more research needed.